tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Seamus Fernandez, 165 are a BUY (79.71%), 42 are a HOLD (20.29%).
Analyst Seamus Fernandez, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 49.18% that have a potential upside of 52.88% achieved within 386 days. Previously, Seamus Fernandez worked at LEERINK.
Seamus Fernandez’s has documented 396 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AMLX, Amylyx Pharmaceuticals at 25-Jun-2026.
Analyst best performing recommendations are on ADGI (ADAGIO THERAPEUTICS).
The best stock recommendation documented was for VIE (VIELA BIO) at 1/7/2020. The price target of $45 was fulfilled within 9 days with a profit of $17.12 (61.41%) receiving and performance score of 68.23.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Dec-2016
$193
$-0.02 (-0.01%)
6 years 2 months 18 days ago
(21-Apr-2020)
2/8 (25%)
$8.96 (4.87%)
125
Hold Since 08-May-2019
$203
$9.98 (5.17%)
$178
6 years 4 months 29 days ago
(10-Feb-2020)
5/19 (26.32%)
$4.87 (2.46%)
74
Buy Since 03-Aug-2017
$198
$4.98 (2.58%)
$188
6 years 5 months 17 days ago
(22-Jan-2020)
3/12 (25%)
$7.8 (4.10%)
176
Buy Since 03-Aug-2015
$200
6 years 7 months 20 days ago
(19-Nov-2019)
2/12 (16.67%)
$73.92 (58.63%)
290
$203
$9.98 (5.17%)
$189
6 years 7 months 20 days ago
(19-Nov-2019)
1/2 (50%)
$19.19 (10.44%)
96
Which stock is Seamus Fernandez is most bullish on?
Which stock is Seamus Fernandez is most reserved on?
What Year was the first public recommendation made by Seamus Fernandez?
